Position in MYGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,416,000
-$105,450 QoQ
Shares Held
1,648,000
+34.8% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Vestal Point Capital, LP holds $57,460,428 across 4 Diagnostics & Research names. MYGN ranks #3 (12.9% of the industry book) .
All Filings in MYGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,416,000 | 1,648,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,521,450 | 1,223,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,338,000 | 600,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||